Between Dec 19, 2024 and Jan 2, 2025, datasets can be submitted to DRUM but will not be processed until after the break. Staff will not be available to answer email during this period, and will not be able to provide DOIs until after Jan 2. If you are in need of a DOI during this period, consider Dryad or OpenICPSR. Submission responses to the UDC may also be delayed during this time.
 

Modeling the Early Identification and Intervention of Alzheimer’s Disease

Loading...
Thumbnail Image

Persistent link to this item

Statistics
View Statistics

Journal Title

Journal ISSN

Volume Title

Title

Modeling the Early Identification and Intervention of Alzheimer’s Disease

Published Date

2015-09

Publisher

Type

Thesis or Dissertation

Abstract

Advances in neuroimaging and biomarkers now provide the ability to detect evidence for the pathophysiological process of Alzheimer’s disease (AD) before clinically detectable dementia. Because of these findings, AD research has begun to focus on the preclinical or prodromal stages of the disease. For example, many clinical trials and laboratory-based studied have examined the clinical benefit of earlier AD intervention, such as pre-symptomatic stages of AD, based on the belief that it is more likely to achieve disease modification. The economic evaluation of potential interventions on AD, which mainly extends to include the earlier disease stages by using biomarker testing to predict the risk of disease progression, needs to be updated. Accordingly, the overall objective of this thesis is to quantify the value of using cerebrospinal fluid (CSF) biomarker testing for early-targeted treatment on patients with mild cognitive impairment who are at risk of developing AD. Firstly, I examined whether CSF biomarker testing can categorize MCI patients into different risk groups of developing AD, and thus allowing for targeted early treatment on MCI patients. Secondly, I conducted a cost-effectiveness analysis to evaluate the different treatment strategies with or without testing information involved by developing a decision model to synthesize all relevant evidence and project the expected value of outcomes of interest for each proposed alternative. Finally, I further address key challenges based on the current evidence by estimating the societal value of reducing uncertainty surrounding the decision model through further research. Economic evidence about the relative costs and outcomes of health and social care can assist decision makers in determining the best use of scarce healthcare resources.

Description

University of Minnesota Ph.D. dissertation. September 2015. Major: Health Services Research, Policy and Administration. Advisor: Karen Kuntz. 1 computer file (PDF); x, 189 pages.

Related to

Replaces

License

Collections

Series/Report Number

Funding information

Isbn identifier

Doi identifier

Previously Published Citation

Other identifiers

Suggested citation

Michaud, Tzeyu. (2015). Modeling the Early Identification and Intervention of Alzheimer’s Disease. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/175512.

Content distributed via the University Digital Conservancy may be subject to additional license and use restrictions applied by the depositor. By using these files, users agree to the Terms of Use. Materials in the UDC may contain content that is disturbing and/or harmful. For more information, please see our statement on harmful content in digital repositories.